MedPath
FDA Product

Enhertu

Product approved by U.S. Food and Drug Administration (US)

Basic Information

Enhertu

65597-406

Regulatory Information

65597-406

BLA761139

C73585

February 22, 2024

USA

These highlights do not include all the information needed to use ENHERTU safely and effectively. See full prescribing information for ENHERTU. ENHERTU (fam-trastuzumab deruxtecan-nxki) for injection, for intravenous use Initial U.S. Approval: 2019

HUMAN PRESCRIPTION DRUG LABEL

17

Company Information

068605067

Active Ingredients

TRASTUZUMAB DERUXTECAN

Quantity: 100 mg in 5 mL

Code: 5384HK7574

Class Code: ACTIB

HISTIDINE

Code: 4QD397987E

Class Code: IACT

HISTIDINE MONOHYDROCHLORIDE MONOHYDRATE

Code: X573657P6P

Class Code: IACT

POLYSORBATE 80

Code: 6OZP39ZG8H

Class Code: IACT

SUCROSE

Code: C151H8M554

Class Code: IACT

Active Moieties

TRASTUZUMAB DERUXTECAN

Code: 5384HK7574

© Copyright 2025. All Rights Reserved by MedPath